Repurposed drugs may offer improved treatments for fatal genetic disorders
Medical Center researchers believe they have identified a potential new means of treating lysosomal storage disorders, some of the most severe genetic diseases of childhood.
Making radiotherapy better for cancer patients
A Medical Center study explains how the benefits of radiation can be hijacked by the treatment’s tendency to dampen the body’s immune response, and suggests that adding immunotherapy to radiotherapy improves treatment.
Study challenges autism brain response theory
A Medical Center study challenges the hypothesis that nerve cells in the brains of individuals with autism spectrum disorders do not reliably and consistently respond to external stimuli.
Physicians create ‘model human’ to practice surgery
Physicians at the Medical Center have developed a new way to fabricate artificial organs and human anatomy that mimics the real thing, even up to the point of bleeding when cut.
‘Antisense’ compounds offer new weapon against influenza A
Challenging a long-held convention, University researchers have shown they can inhibit the influenza A virus by targeting its genomic RNA with “antisense” compounds.
Study shows e-cigarettes cause damage to gum tissue
In the the first scientific study to address e-cigarettes and their effect on oral health at the cellular level, Medical Center research suggests that electronic cigarettes are as equally damaging to gums and teeth as conventional cigarettes.
Repurposed drug may offer treatment for nerve damage
Medical Center researchers believe they have identified a new means of enhancing the body’s ability to repair its own cells, which they hope will lead to better diagnosis and treatment of traumatic nerve injuries, like those sustained in car accidents, sports injuries, or in combat.
Seed grant enables researchers to try new approach to targeting leukemia
University researchers hope to improve the odds of surviving acute myeloid leukemia by loading a promising compound into nanoparticles that will target the inner recesses of bone marrow where leukemia stem cells lurk.
Research to explore new therapies for Huntington’s disease
A new grant anticipated to total more than $10.5 million over next five years will help Medical Center scientists develop a stem cell-based therapy that swaps sick brain cells for healthy ones.
Wilmot scientists exploit cell metabolism to attack cancer
Medical Center researchers have shown for the first time how cancer-causing mutations control and alter the way cancer cells biosynthesize and replicate.